Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells

Molecular and Cellular Biochemistry

Volumn 405, Issue 1-2, 2015, Pages 205-221

  Linher Melville, Katja ^a   Haftchenary, Sina ^b   Gunning, Patrick ^b   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Oxidative stress; SLC7A11; STAT3; STAT5; System Xc ; xCT

Indexed keywords

ANTIPORTER; CYSTINE; GLUTAMIC ACID; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STAT3 PROTEIN; STAT5A PROTEIN; SYSTEM XC; UNCLASSIFIED DRUG; MESSENGER RNA; STAT3 PROTEIN, HUMAN; STAT5 PROTEIN; STAT5A PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID TRANSPORT; ARTICLE; BREAST CANCER CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; GENE MUTATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYSTINE; FEMALE; GLUTAMIC ACID; GLUTATHIONE; HUMANS; OXIDATION-REDUCTION; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84929962968     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2412-4     Document Type: Article

References (71)

1. Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P (2013) The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18:522–555. doi:10.1089/ars.2011.4391
2. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19:387–400. doi:10.1016/j.ccr.2011.01.038
3. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S (2005) Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280:37423–37429. doi:10.1074/jbc.M506439200
4. Lo M, Wang YZ, Gout PW (2008) The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215:593–602. doi:10.1002/jcp.21366
5. Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX, Zhan QM, Li W (2009) Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene 28:599–609. doi:10.1038/onc.2008.414
6. Huang Y, Dai Z, Barbacioru C, Sadee W (2005) Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65:7446–7454. doi:10.1158/0008-5472.CAN-04-4267
7. Pham AN, Blower PE, Alvarado O, Ravula R, Gout PW, Huang Y (2010) Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. J Pharmacol Exp Ther 332:949–958. doi:10.1124/jpet.109.162248
8. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 447:532–542. doi:10.1007/s00424-003-1086-z
9. Bannai S (1984) Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents. J Biol Chem 259:2435–2440
10. Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S (2004) Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun 325:109–116. doi:10.1016/j.bbrc.2004.10.009
11. Bannai S, Sato H, Ishii T, Sugita Y (1989) Induction of cystine transport activity in human fibroblasts by oxygen. J Biol Chem 264:18480–18484
12. Sato H, Fujiwara K, Sagara J, Bannai S (1995) Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 310(Pt 2):547–551
13. Jackman NA, Uliasz TF, Hewett JA, Hewett SJ (2010) Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1 beta: implications for hypoxic neuronal injury. Glia 58:1806–1815. doi:10.1002/glia.21050
14. Sims B, Clarke M, Njah W, Hopkins ES, Sontheimer H (2010) Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity. Brain Res 1321:88–95. doi:10.1016/j.brainres.2010.01.040
15. Liu X, Resch J, Rush T, Lobner D (2012) Functional upregulation of system xc- by fibroblast growth factor-2. Neuropharmacology 62:901–906. doi:10.1016/j.neuropharm.2011.09.019
16. Yang Y, Yee D (2014) IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC. Cancer Res 74:2295–2305. doi:10.1158/0008-5472.CAN-13-1803
17. Lall MM, Ferrell J, Nagar S, Fleisher LN, McGahan MC (2008) Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase. Invest Ophthalmol Vis Sci 49:310–319. doi:10.1167/iovs.07-1041
18. Du J, Li XH, Zhang W, Yang YM, Wu YH, Li WQ, Peng J, Li YJ (2014) Involvement of glutamate-cystine/glutamate transporter system in aspirin-induced acute gastric mucosa injury. Biochem Biophys Res Commun 450:135–141. doi:10.1016/j.bbrc.2014.05.069
19. Lin X, Yang H, Zhang H, Zhou L, Guo Z (2013) A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1). J Biol Chem 288:14815–14823. doi:10.1074/jbc.M113.466565
20. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, He M, Chen GQ, He JR, Zhao Q (2011) MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 585:1363–1367. doi:10.1016/j.febslet.2011.04.018
21. Kilberg MS, Shan J, Su N (2009) ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol Metab 20:436–443. doi:10.1016/j.tem.2009.05.008
22. Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, Ohyama C, Itoh K (2014) Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol 34:3421–3434. doi:10.1128/MCB.00221-14
23. Moi P, Chan K, Asunis I, Cao A, Kan YW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 91:9926–9930
24. Zhang DD (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38:769–789. doi:10.1080/03602530600971974
25. Ishii T, Sugita Y, Bannai S (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J Cell Physiol 133:330–336. doi:10.1002/jcp.1041330217
26. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, Bannai S (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277:44765–44771. doi:10.1074/jbc.M208704200
27. Tsujita T, Peirce V, Baird L, Matsuyama Y, Takaku M, Walsh SV, Griffin JL, Uruno A, Yamamoto M, Hayes JD (2014) Transcription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymes. Mol Cell Biol 34:3800–3816. doi:10.1128/MCB.00110-14
28. Yamamoto M, Takeda K (2010) Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010:240365. doi:10.1155/2010/240365
29. Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, Mann GE, Bannai S (2001) Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biol Chem 276:10407–10412. doi:10.1074/jbc.M007216200
30. Gupta S (2002) A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol 22:185–194
31. Lastro M, Kourtidis A, Farley K, Conklin DS (2008) xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal 20:390–399. doi:10.1016/j.cellsig.2007.10.030
32. Kobierski LA, Srivastava S, Borsook D (2000) Systemic lipopolysaccharide and interleukin-1 beta activate the interleukin 6: STAT intracellular signaling pathway in neurons of mouse trigeminal ganglion. Neurosci Lett 281:61–64
33. Miscia S, Marchisio M, Grilli A, Di Valerio V, Centurione L, Sabatino G, Garaci F, Zauli G, Bonvini E, Di Baldassarre A (2002) Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ 13:13–18
34. Bittorf T, Jaster R, Ludtke B, Kamper B, Brock J (1997) Requirement for JAK2 in erythropoietin-induced signalling pathways. Cell Signal 9:85–89
35. Dudka AA, Sweet SM, Heath JK (2010) Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. Cancer Res 70:3391–3401. doi:10.1158/0008-5472.CAN-09-3033
36. Xiong A, Yang Z, Shen Y, Zhou J, Shen Q (2014) Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancers (Basel) 6:926–957. doi:10.3390/cancers6020926
37. Haftchenary S, Luchman HA, Jouk AO, Veloso AJ, Page BD, Cheng XR, Dawson SS, Grinshtein N, Shahani VM, Kerman K, Kaplan DR, Griffin C, Aman AM, Al-Awar R, Weiss S, Gunning PT (2013) Potent targeting of the STAT3 protein in brain cancer stem cells: a promising route for treating glioblastoma. ACS Med Chem Lett 4:1102–1107. doi:10.1021/ml4003138
38. Ginsberg M, Czeko E, Muller P, Ren Z, Chen X, Darnell JE Jr (2007) Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos. Mol Cell Biol 27:6300–6308. doi:10.1128/MCB.00613-07
39. Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11–19. doi:10.1016/j.cytogfr.2009.11.005
40. Magne S, Caron S, Charon M, Rouyez MC, Dusanter-Fourt I (2003) STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol 23:8934–8945
41. Bourgeais J, Gouilleux-Gruart V, Gouilleux F (2013) Oxidative metabolism in cancer: a STAT affair? JAKSTAT 2:e25764. doi:10.4161/jkst.25764
42. Turei D, Papp D, Fazekas D, Foldvari-Nagy L, Modos D, Lenti K, Csermely P, Korcsmaros T (2013) NRF2-ome: an integrated web resource to discover protein interaction and regulatory networks of NRF2. Oxid Med Cell Longev 2013:737591. doi:10.1155/2013/737591
43. Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972–978. doi:10.1038/nature05836
44. Fukui H, Sekikawa A, Tanaka H, Fujimori Y, Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T, Fujimori T (2011) DMBT1 is a novel gene induced by IL-22 in ulcerative colitis. Inflamm Bowel Dis 17:1177–1188. doi:10.1002/ibd.21473
45. Linher-Melville K, Singh G (2014) The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells. BMC Cancer 14:415. doi:10.1186/1471-2407-14-415
46. Domercq M, Sanchez-Gomez MV, Sherwin C, Etxebarria E, Fern R, Matute C (2007) System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178:6549–6556
47. Horvath CM, Wen Z, Darnell JE Jr (1995) A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9:984–994
48. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL (1995) Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2:689–697
49. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92:3041–3045
50. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579–591. doi:10.1038/nrd2803
51. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95. doi:10.1038/nrc2981
52. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10:1343–1374. doi:10.1089/ars.2007.1957
53. Schneider BL, Kulesz-Martin M (2004) Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis 25:2033–2044. doi:10.1093/carcin/bgh204
54. Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR III, Felding-Habermann B (2007) Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67:1472–1486. doi:10.1158/0008-5472.CAN-06-3137
55. Sullivan R, Graham CH (2008) Chemosensitization of cancer by nitric oxide. Curr Pharm Des 14:1113–1123
56. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, Griffin JD (1999) Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93:2928–2935
57. Iiyama M, Kakihana K, Kurosu T, Miura O (2006) Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 18:174–182. doi:10.1016/j.cellsig.2005.04.002
58. Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005–L1028
59. Simon AR, Rai U, Fanburg BL, Cochran BH (1998) Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275:C1640–C1652
60. Kaur N, Lu B, Monroe RK, Ward SM, Halvorsen SW (2005) Inducers of oxidative stress block ciliary neurotrophic factor activation of Jak/STAT signaling in neurons. J Neurochem 92:1521–1530. doi:10.1111/j.1471-4159.2004.02990.x
61. Di Bona D, Cippitelli M, Fionda C, Camma C, Licata A, Santoni A, Craxi A (2006) Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 45:271–279. doi:10.1016/j.jhep.2006.01.037
62. Aharoni-Simon M, Reifen R, Tirosh O (2006) ROS-production-mediated activation of AP-1 but not NFkappaB inhibits glutamate-induced HT4 neuronal cell death. Antioxid Redox Signal 8:1339–1349. doi:10.1089/ars.2006.8.1339
63. Gutzman JH, Rugowski DE, Nikolai SE, Schuler LA (2007) Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene 26:6341–6348. doi:10.1038/sj.onc.1210454
64. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–868. doi:10.1038/nrc1209
65. Arakawa M, Ito Y (2007) N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 6:308–314. doi:10.1080/14734220601142878
66. Hradetzky S, Roesner LM, Balaji H, Heratizadeh A, Mittermann I, Valenta R, Werfel T (2014) Cytokine effects induced by the human autoallergen alpha-NAC. J Invest Dermatol 134:1570–1578. doi:10.1038/jid.2014.25
67. Wang T, Mao X, Li H, Qiao S, Xu A, Wang J, Lei S, Liu Z, Ng KF, Wong GT, Vanhoutte PM, Irwin MG, Xia Z (2013) N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med 63:291–303. doi:10.1016/j.freeradbiomed.2013.05.043
68. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513. doi:10.1038/sj.onc.1204349
69. Yamashita H, Iwase H (2002) The role of Stat5 in estrogen receptor-positive breast cancer. Breast Cancer 9:312–318
70. Nowakowski BE, Maurer RA (1994) Multiple Pit-1-binding sites facilitate estrogen responsiveness of the prolactin gene. Mol Endocrinol 8:1742–1749. doi:10.1210/mend.8.12.7708061
71. Balza E, Castellani P, Delfino L, Truini M, Rubartelli A (2013) The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis. Carcinogenesis 34:620–626. doi:10.1093/carcin/bgs360